Organic pigments used to produce yellow, red, blue and green colors are more likely to change color after prolonged residence time or high regrind levels. 350- 370°F (175- 190°C)

ECCOH™ INSULATION GRADES APPLICATIONS ECCOH GRADES MFR (150C/ 21.6kg) TS (MPa) EB (%) LOI (%O2) COMMENTS Data Insulation 5918 15.7 14.5 210 35 Excellent processability with high mechanical Data Insulation 6200 D 11.0 14 350 30 Low thickness and high speed processing.

ECCOH™ INSULATION GRADES APPLICATIONS ECCOH GRADES MFR (150C/ 21.6kg) TS (MPa) EB (%) LOI (%O2) COMMENTS Data Insulation 5918 15.7 14.5 210 35 Excellent processability with high mechanical Data Insulation 6200 D 11.0 14 350 30 Low thickness and high speed processing.

Organic pigments used to produce yellow, red, blue and green colors are more likely to change color after prolonged residence time or high regrind levels. Product Family and Temperatures Product Family Mold Melt Nozzle Zone 3 Zone 2 Zone 1 Feed SBS Formulations 75-90ºF (25-32ºC) 370-390ºF 200ºC) 370-390ºF 200ºC) 360-380ºF (185- 195ºC) 340-360ºF 182ºC) 300-330ºF (150- 165ºC) 100-150ºF (40-65ºC) SEBS Formulations 110-130ºF (43-55ºC) 370-430ºF 220ºC) 390-430ºF (200- 220ºC) 390-430ºF (200- 220ºC) 370-390ºF 200ºC) 350-370ºF (175- 190ºC) 100-170ºF (40-75ºC) Supersoft Formulations 110-130ºF (43-55ºC) 340-390ºF 200ºC) 360-390ºF (180- 200ºC) 360-390ºF (180- 200ºC) 335-375ºF 190ºC) 300-330ºF (150- 165ºC) 100-120ºF (40-50ºC) Setting Shot Size When starting up a new mold, begin with short-shots, then gradually increase the shot size until all part cavities are 80-90% filled.

These shares, as well as the annual retainer consisting of fulff ly vested common shares, may also be deferff red under the Deferred Compensation Plan. Deferff red compensation, whether in the form of cash or common shares, is held in trust for the participating Directors. Patterson’s opportunity was increased from 325% to 350% to reflect his increasing experience in the CEO role; Mr.

FP compounds for: PFA, FEP, ECA, ETFE, ECTFE, PTFE, and PVDF HTP compounds for: PEI, PES, PSU, PPSU, PPS, LCP, PEEK, PAEK, and PEKEKK Colorant Chromatics specialty compounds offer property enhancements such as: • Mechanical strength • Static dissipation • X-ray opacity • Electrical performance • Low dielectric performance • Mold release • Laser marking • Transcend™ Premier Healthcare Colorants (biocompatible) ADDITIVE CONCENTRATE FORMULATIONS Colorant Chromatics additive solutions can provide your solutions with additional functionality such as: • Improved lubricity • Lightweighting through foaming, by both physical and chemical foaming • Heat reduction through �SiteCool™ infra-red absorption technologies for roofing applications • Laser marking solutions or other added value properties NON-PFAS MOLD RELEASE ADDITIVES Colorant Chromatics™ Evoluscend™ is a non-PFAS* high-temperature polymer mold release additive developed to boost production efficiency and product quality for manufacturers.

EPS $0.14 $2.67 $3.04 TOP-TIER SUSTAINABILITY PERFORMANCE AND RECOGNITION Industry Sustainability Standards 90th percentile 84th ESG Ratings Performance 1 10 PEOPLE C U L T U R E I S E V E R Y T H I N G Community Service 7x Safer than Industry Average World-Class Safety Leadership Development Over $17 million raised since 2010 Diversity & Inclusion 11 2022 RE SU LT S Q4 EBITDA BRIDGE (PRO FORMA TOTAL COMPANY) 13 $ millions CAI: Price / Mix 42 Inflation (20) SEM: Price / Mix 14 Inflation (10) Net Price Benefit 26 Wage and Energy Inflation (13) Clariant Color Integration Synergies 4 Incentives, Other Employee Costs 21 FX (10) Q4 2022 $107 Adjusted Q4 2021 $ 132 Demand (50) Russia Import Sales (3) • Demand contraction especially prevalent in EMEA and Asia • Pricing continues to cover inflation of raw materials, wages and energy PROVEN TRACK RECORD OF STRONG AND IMPROVING FREE CASH FLOW GENERATION 14 • Periods of economic weakness have driven higher levels of cash generation due to working capital management • Anticipate continued strong free cash flow generation and conversion despite global uncertainty 78% 78% 80% 80% 81% 78% 84% 83% 80% 0% 30% 40% 50% 60% 70% 80% 90% 2014 2015 2016 2017 2018 2019 2020 2021 2022 0 50 100 150 200 250 300 350 400 re e as h F lo w C o n ve rs io n re e as h F lo w FCF $ AVNT FCF Conversion % S&P FCF Conversion % Note: Free cash flow conversion calculated as (Adjusted EBITDA – Capex) / Adjusted EBITDA. 2020 is pro forma for Clariant Color and 2022 is pro forma for Avient Protective Materials $600 $592 $3.02 $3.04 FULL YEAR 2022 PERFORMANCE (TOTAL COMPANY PRO FORMA) 15 Sales Adjusted EBITDA $3,712 $3,653 -2% Adjusted EPS -1% + 1% (in millions) (in millions) (+4% excluding FX) (+5% excluding FX) (+9% excluding FX) FULL YEAR 2022 SEGMENT PERFORMANCE 16 CAI $2,402 $2,355 $409 $402 SEM Pro Forma $1,308 $1,300 $278 $272 (+4% excluding FX) - 2% -1% (+5% excluding FX) - 2% (+4% excluding FX) - 2% (+2% excluding FX) PRO FORMA FULL YEAR EPS BRIDGE 17 Pro Forma 2021 Adjusted EPS 3.02$ Foreign Currency (0.23) Russia Import Sales (0.07) Outdoor High Performance (0.13) Color, Additives and Inks 0.18 Specialty Engineered Materials 0.24 Corporate Costs / Other 0.03 Pro Forma 2022 Adjusted EPS 3.04$ FULL YEAR EBITDA BRIDGE (PRO FORMA TOTAL COMPANY) 18 $ millions CAI: Price / Mix 247 Inflation (176) SEM: Price / Mix 121 Inflation (77) Net Price Benefit 115 Wage and Energy Inflation (47) Clariant Color Integration Synergies 23 Incentives, Other Employee Costs 43 FX (34) Full Year 2022 $592 Adjusted Full Year 2021 $ 600 Demand (99) Russia Import Sales (9) • Demand primarily impacted by China lockdowns, 4th quarter industrywide destocking and declining consumer sentiment • Pricing outpaced inflation of raw materials, wages and energy 2023 G U IDA N CE $125 $530 $0.55 $2.40 2023 GUIDANCE 20 Sales Adjusted EBITDA $845 $3,450 Adjusted EPS (in millions) (in millions) CASH FLOW / BALANCE SHEET 21 • IT investment to further integrate acquired businesses and capture operational efficiencies • Restructuring actions to streamline operations and improve profitability, primarily in Europe ($ millions) 2023E Cash Flow from Operating Activities 350$ Less: Run-Rate CapEx (110) CapEx for IT System Upgrade (25) CapEx for Restructuring (15) Total CapEx (150) Free Cash Flow 200$ Adjusted EBITDA 530$ Net Debt / Adjusted EBITDA 2.9x K E Y G R O W T H D R I V E R S A N D T R A N S F O R M E D P O R T F O L I O GROWTH DRIVERS: PROVEN SUCCESS 23 (1) Pro forma for the acquisition of Avient Protective Materials (APM) COMPOSITES $51 $84 $212 $668 HEALTHCARE $108 $113 $231 $293 8-10% ASIA/EMERGING REGIONS $265 $358 $726 $830 12% $340 $455 $790 $1,175 SUSTAINABLE SOLUTIONS 8-12% (1) (1)(1) (Sales in $ millions) #1 Color Formulator Dyneema® - World’s Strongest Fiber™ #1 in Composites applications for outdoor high performance #1 in Performance Inks Customized solutions 140+ PhDs on staff Rapid development of innovative products Extensive patent (2,500+) portfolio 33% Vitality Index Better-positioned toward stable, high-growth end markets Consumer, packaging, healthcare and defense comprise nearly 60% of sales Agnostic to raw materials, helping all customers achieve their goals Broad portfolio of diversified sustainable solutions 90%+ of our innovation pipeline invested in sustainable solutions Long-term growth rate well above GDP with expectations of 8-12% LEVERAGING OUR TRANSFORMED PORTFOLIO 24 Building & 4% Telecom. 2022 PF $3.65B sales Leading Positions Sustainable SolutionsDiversified IndustriesSpecialty Formulator (1) 2022 Pro forma for the acquisition of Avient Protective Materials (2) 2020 Pro forma for the acquisition of Clariant Color (1)(2) $340M $455M $790M 2016 2018 2020PF 2022PF $1,175M P EE R C O M PAR IS O N S AVIENT IS ASSET LIGHT Capex / Revenue 2023E (%) Avient Specialty Other Specialty / Note: Avient reflects 2023 estimated revenue of $3,450 and estimated run-rate CAPEX of $110M. 27 2 4 4 5 5 5 6 7 7 FREE CASH FLOW CONVERSION Note: Free cash flow conversion calculated as (Adjusted EBITDA – Capex) / Adjusted EBITDA.

Base Resin ABS PA PBT PC PE PEEK PP PPS Barrel Temperatures °F (°C) Rear Zone 400–475 (200–250) 430–500 480–520 (250–270) 480–570 (250–300) 400–445 (200–230) 660–700 (350–475) 400–440 (200–225) 520–600 (270–300) Center Zone 410–480 (205–253) 440–510 (225–265) 483–522 (252–272) 500–580 (260–305) 410–455 (207–237) 670–710 (357–385) 410–450 (205–230) 550–610 (285–310) Front Zone 420–490 (210–257) 450–520 (230–270) 487–527 (254–274) 515–590 (267–310) 420–465 (213–243) 680–720 (363–400) 420–455 (215–235) 570–620 (300–320) Nozzle 425–500 (215–260) 460–530 (235–275) 490–530 (255–275) 530–600 (275–315) 700–730 (370–395) 430–460 (220–240) 610–620 (320–325) Melt Temperature 425–515 (215–270) 530–580 (276–300) 500–565 (260–300) 530–615 (275–325) 430–495 700–725 (370–385) 610–635 (320–335) Mold Temperature 140–200 (60–90) 150–200 (65–90) 140–250 (60–120) 160–240 (70–115) 300–400 (150–200) 190–300 (90–150) Drying Parameters 190 (90) 2–4 Hours 0.01%–0.15% 180 (80) 4–5 Hours 0.10%–0.20% 275 (135) 0.02%–0.04% 250 (125) 0.02% 300 (150) 0.10% 280 (135) 2–3 Hours 0.01%–0.20% Nozzle Type General Purpose Nylon or ReverseTaper General Purpose General Purpose General Purpose General Purpose General Purpose General Purpose Injection Velocity1 2.0–5.0 in/sec; 50–125 mm/sec Injection Pressure 2,000–4,000 psi; 13,000–30,000 kpa Back Pressure 0–50 psi; 0–350 kpa Screw Speed 25–75 RPM Cushion 0.125"–0.250"; 3.175 mm–6.35 mm Screw Compression Ratio2 2.0:1–2.5:1 Design Guide 7 Base Resin ABS PA PBT PC PE PEEK PP PPS Barrel Temperatures °F (°C) Rear Zone 400–475 (200–250) 430–500 480–520 (250–270) 480–570 (250–300) 400–445 (200–230) 660–700 (350–475) 400–440 (200–225) 520–600 (270–300) Center Zone 410–480 (205–253) 440–510 (225–265) 483–522 (252–272) 500–580 (260–305) 410–455 (207–237) 670–710 (357–385) 410–450 (205–230) 550–610 (285–310) Front Zone 420–490 (210–257) 450–520 (230–270) 487–527 (254–274) 515–590 (267–310) 420–465 (213–243) 680–720 (363–400) 420–455 (215–235) 570–620 (300–320) Nozzle 425–500 (215–260) 460–530 (235–275) 490–530 (255–275) 530–600 (275–315) 700–730 (370–395) 430–460 (220–240) 610–620 (320–325) Melt Temperature 425–515 (215–270) 530–580 (276–300) 500–565 (260–300) 530–615 (275–325) 430–495 700–725 (370–385) 610–635 (320–335) Mold Temperature 140–200 (60–90) 150–200 (65–90) 140–250 (60–120) 160–240 (70–115) 300–400 (150–200) 190–300 (90–150) Drying Parameters 190 (90) 2–4 Hours 0.01%–0.15% 180 (80) 4–5 Hours 0.10%–0.20% 275 (135) 0.02%–0.04% 250 (125) 0.02% 300 (150) 0.10% 280 (135) 2–3 Hours 0.01%–0.20% Nozzle Type General Purpose Nylon or ReverseTaper General Purpose General Purpose General Purpose General Purpose General Purpose General Purpose Injection Velocity1 2.0–5.0 in/sec; 50–125 mm/sec Injection Pressure 2,000–4,000 psi; 13,000–30,000 kpa Back Pressure 0–50 psi; 0–350 kpa Screw Speed 25–75 RPM Cushion 0.125"–0.250"; 3.175 mm–6.35 mm Screw Compression Ratio2 2.0:1–2.5:1 Comments 1. PLET 350 – Plastic Part Design, Jason Williams, Spring 2014, Penn State Erie, The Behrend College. 2.

S&P 500 -150% -50% 50% 150% 250% 350% 450% 550% POL S&P 500 All time high of $43.34 July 1st, 2014 PolyOne Corporation Page 9 2006 2014 YTD 2015 “Where we were” “Where we are” Target 1) Operating Income % Specialty: Global Color, Additives & Inks 1.7% 14.9% 12 – 16% Global Specialty Engineered Materials 1.1% 12.1% 12 – 16% Designed Structures & Solutions -- 7.6% 8 – 10% Performance Products & Solutions 5.5% 8.1% 9 – 12% Distribution 2.6% 6.2% 6 – 7.5% 2) Specialty Platform % of Operating Income 6.0% 65% 65 – 75% 3) ROIC* 5.0% 10.6% 15% 4) Adjusted EPS Growth N/A 37% Double Digit Expansion Proof of Performance & 2015 Goals *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period PolyOne Corporation Page 10 32% Adjusted EPS CAGR from 2011 2015 EPS: $2.50 2011 EPS: $0.82 Continued Gross Margin Expansion Mergers & Acquisitions Spartech Accretion Incremental Share Buybacks Ongoing LSS Programs (50-100 bps/yr) Accelerated Innovation & Mix Improvement Several Levers to Drive Growth Mid Single Digit Revenue Growth PolyOne Corporation Page 11 Innovation Drives Earnings Growth *Percentage of Specialty Platform revenue from products introduced in last five years $20 $53 2006 2013 Research & Development Spending ($ millions) Specialty Platform Vitality Index Progression* 14% 31% 2006 2013 Specialty Platform Gross Margin % 20% 43% 2006 2013 Specialty Vitality Index Target ≥ 35% Vitality Products + 700 to 1000 bps PolyOne Corporation Page 12 Prototype Frame Opportunity Scale-up & Test Market Build Business Case Commercial Launch Phase 1 Phase 2 Phase 3 Phase 4 Phase 5 4 11 5 10 6 9 3 4 2 15 9 1 10 4 Breakthrough Platform Derivative A Rich Pipeline of Opportunity Number of Projects 25 14 19 17 18 93 Addressable Market ($ millions) TBD TBD $800 $450 $450 $1,700 PolyOne Corporation Page 13 Megatrends Aligned with Key End Markets Decreasing Dependence on Fossil Fuels Protecting the Environment Improving Health and Wellness Megatrend End Markets Globalizing and Localizing Health & Wellness Transportation Packaging Consumer PolyOne Corporation Page 14 60% 100% 20% 30% 40% 50% 60% 70% 80% 90% 100% 2008 2014 Pension Funding** As of September 30, 2014 Debt Maturities & Pension Funding – 9/30/14 Net Debt / EBITDA* = 1.7x $48 $317 $600 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2020 2023 Debt Maturities As of September 30, 2014 ($ millions) Coupon Rates: 7.500% 7.375% 5.250% ** includes US-qualified pension plans only *TTM 9/30/2014 PolyOne Corporation Page 15 Free Cash Flow and Strong Balance Sheet Fund Investment / Shareholder Return Expanding our sales, marketing, and technical capabilities Targets that expand our: • Specialty offerings • End market presence • Geographic footprint • Operating Margin Synergy opportunities Adjacent material solutions Repurchased 1.5 million shares in Q3 2014 Repurchased 9.7 million shares since early 2013  10.3 million shares are available for repurchase under the current authorization Organic Growth Acquisitions Share Repurchases Dividends  Investing in operational and LSS initiatives (including synergy capture) Manufacturing alignment $0.16 $0.20 $0.24 $0.32 $0.40 $0.10 $0.20 $0.30 $0.40 $0.50 2011 2012 2013 2014 2015 Annual Dividend PolyOne Corporation Page 16 PolyOne Core Values Innovation Collaboration Excellence PolyOne Corporation Page 17 The New PolyOne: A Specialty Growth Company Why Invest In PolyOne?

S&P 500 -150% -50% 50% 150% 250% 350% 450% 550% POL S&P 500 All time high of $43.34 July 1st, 2014 PolyOne Corporation Page 9 2006 2014 YTD 2015 “Where we were” “Where we are” Target 1) Operating Income % Specialty: Global Color, Additives & Inks 1.7% 15.2% 12 – 16% Global Specialty Engineered Materials 1.1% 11.8% 12 – 16% Designed Structures & Solutions -- 7.1% 8 – 10% Performance Products & Solutions 5.5% 8.0% 9 – 12% Distribution 2.6% 6.0% 6 – 7.5% 2) Specialty Platform % of Operating Income 6.0% 66% 65 – 75% 3) ROIC* 5.0% 9.9% 15% 4) Adjusted EPS Growth N/A 40% Double Digit Expansion Proof of Performance & 2015 Goals *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period (Est. in 2012) PolyOne Corporation Page 10 Bridge to $2.50 Adjusted EPS by 2015 2015 EPS: $2.50 2013 EPS: $1.31 Continued Gross Margin Expansion Mergers & Acquisitions Spartech Accretion Incremental Share Buybacks Ongoing LSS Programs (50-100 bps/yr) Accelerated Innovation & Mix Improvement Several Levers to Drive Growth Mid Single Digit Revenue CAGR PolyOne Corporation Page 11 Innovation Drives Earnings Growth *Percentage of Specialty Platform revenue from products introduced in last five years $20 $53 2006 2013 Research & Development Spending ($ millions) Specialty Platform Vitality Index Progression* 14.3% 30.7% 2006 2013 Specialty Platform Gross Margin % 19.5% 43.0% 2006 2013 Specialty Vitality Index Target ≥ 35% PolyOne Corporation Page 12 Prototype Frame Opportunity Scale-up & Test Market Build Business Case Commercial Launch Phase 1 Phase 2 Phase 3 Phase 4 Phase 5 4 11 5 10 6 9 3 4 2 15 9 1 10 4 Breakthrough Platform Derivative A Rich Pipeline of Opportunity* Number of Projects 25 14 19 17 18 93 Addressable Market ($ millions) TBD TBD $800 $450 $450 $1,700 *Pipeline as of May 29, 2014 as presented during our Innovation Day PolyOne Corporation Page 13 Megatrends Aligned with Key End Markets Decreasing Dependence on Fossil Fuels Protecting the Environment Improving Health and Wellness Megatrend End Markets Globalizing and Localizing Health & Wellness Transportation Packaging Consumer PolyOne Corporation Page 14 60% 100% 20% 30% 40% 50% 60% 70% 80% 90% 100% 2008 2014 Pension Funding** As of June 30, 2014 Debt Maturities & Pension Funding – 6/30/14 Net Debt / EBITDA* = 1.8x $48 $317 $600 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2020 2023 Debt Maturities As of June 30, 2014 ($ millions) Coupon Rates: 7.500% 7.375% 5.250% ** includes US-qualified pension plans only *TTM 6/30/2014 PolyOne Corporation Page 15 Free Cash Flow and Strong Balance Sheet Fund Investment / Shareholder Return $0.16 $0.20 $0.24 $0.32 $0.10 $0.20 $0.30 $0.40 2011 2012 2013 2014 Annual Dividend Expanding our sales, marketing, and technical capabilities Targets that expand our: • Specialty offerings • End market presence • Geographic footprint • Operating Margin Synergy opportunities Adjacent material solutions Repurchased 1.8 million shares in Q2 2014 Repurchased 8.2 million shares since early 2013  11.8 million shares are available for repurchase under the current authorization Organic Growth Acquisitions Share Repurchases Dividends  Investing in operational and LSS initiatives (including synergy capture) Manufacturing alignment PolyOne Corporation Page 16 PolyOne Core Values Innovation Collaboration Excellence PolyOne Corporation Page 17 The New PolyOne: A Specialty Growth Company Why Invest In PolyOne?